Eveline Stock, MD
Associate Professor
Medicine
School of Medicine

Dr. Eveline Oestreicher Stock is a cardiologist specializing in general cardiology and cholesterol metabolism disorders. Her special interests include preventive cardiology, mechanisms of coronary artery disease, heart disease risk assessment, and heart disease women and in the young.

Education & Training

Show all (7) Hide

• Diversity, Equity, and Inclusion Champion Training University of California 2018
• Advanced Lipid Disorders Cardiovascular Research Institute University of California, San Francisco 2013
• Fellowship Preventive Cardiology University of California, San Francisco 2012
• Fellowship Cardiology University of California, San Francisco 2010
• Residency Medicine Harvard School of Medicine - Massachusetts General Hospital 2007
• Fellowship Endocrinology P. Universidad Catolica de Chile 1999
• M.D. School of Medicine P. Universidad Catolica de Chile 1994

Publications (23)

Top publication keywords:
Cardiovascular DiseasesDyslipidemiasNatriuretic Peptide, BrainMineralocorticoid Receptor AntagonistsSterol EsteraseSpironolactoneHypertriglyceridemiaTroponin TAircraftWomen's HealthVascular StiffnessPeptide FragmentsHyperlipidemiasHigh-Density Lipoproteins, Pre-betaWolman Disease

• APOL1 Risk Variants Associate With the Prevalence of Stroke in African American Current and Past Smokers.
  Journal of the American Heart Association 2023 Rakic JM, Pullinger CR, Van Blarigan EL, Movsesyan I, Stock EO, Malloy MJ, Kane JP
• APOL1 Risk Variants Associate with the Prevalence of Stroke in African American Current and Past Smokers.
  medRxiv : the preprint server for health sciences 2023 Rakic JM, Pullinger CR, Van Blarigan EL, Movsesyan I, Stock EO, Malloy MJ, Kane JP
• Early identification and treatment of women's cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers.
  Clinical cardiology 2022 Ivey SL, Hanley HR, Taylor C, Stock E, Vora N, Woo J, Johnson S, Bairey Merz CN, Right Care Women's Cardiovascular Writing Group
• Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokers.
  Chronic obstructive pulmonary diseases (Miami, Fla.) 2022 Mustra Rakic J, Zeng S, Rohdin-Bibby L, Van Blarigan EL, Liu X, Ma S, Kane JP, Redberg RF, Turino GM, Oestreicher Stock E, Arjomandi M
• Machine learning and statistical approaches for classification of risk of coronary artery disease using plasma cytokines.
  BioData mining 2021 Saharan SS, Nagar P, Creasy KT, Stock EO, Feng J, Malloy MJ, Kane JP

Show all (18 more) Hide

• Vascular Aging Is Accelerated in Flight Attendants With Occupational Secondhand Smoke Exposure.
  Journal of occupational and environmental medicine 2019 Wei J, Shufelt C, Oestreicher Stock E, Mills C, Dhawan S, Jacob R, Torbati T, Cook-Wiens G, Benowitz N, Jacob P, Ganz P, Bairey Merz CN, Redberg R
• Levels of prebeta-1 high-density lipoprotein are elevated in 3 phenotypes of dyslipidemia.
  Journal of clinical lipidology 2017 Stock EO, Ferrara CT, O'Connor PM, Naya-Vigne JM, Frost PH, Malloy MJ, Kane JP, Pullinger CR
• Moderate statin treatment reduces prebeta-1 high-density lipoprotein levels in dyslipidemic patients.
  Journal of clinical lipidology 2017 Quinn AG, Schwemberger R, Stock EO, Movsesyan I, Axtell A, Chang S, Ishida BY, Malloy MJ, Kane JP, Pullinger CR
• Identification and metabolic profiling of patients with lysosomal acid lipase deficiency.
  Journal of clinical lipidology 2015 Pullinger CR, Stock EO, Movsesyan I, Malloy MJ, Frost PH, Tripuraneni R, Quinn AG, Ishida BY, Schaefer EJ, Asztalos BF, Kane JP
• Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function.
  JAMA neurology 2014 Mak AC, Pullinger CR, Tang LF, Wong JS, Deo RC, Schwarz JM, Gugliucci A, Movsesyan I, Ishida BY, Chu C, Poon A, Kim P, Stock EO, Schaefer EJ, Asztalos BF, Castellano JM, Wyss-Coray T, Duncan JL, …
• Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency.
  Journal of hepatology 2014 Valayannopoulos V, Malinova V, Honzík T, Balwani M, Breen C, Deegan PB, Enns GM, Jones SA, Kane JP, Stock EO, Tripuraneni R, Eckert S, Schneider E, Hamilton G, Middleton MS, Sirlin C, Kessler B, …
• Short-term physical inactivity impairs vascular function.
  The Journal of surgical research 2014 Nosova EV, Yen P, Chong KC, Alley HF, Stock EO, Quinn A, Hellmann J, Conte MS, Owens CD, Spite M, Grenon SM
• Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease.
  Hepatology (Baltimore, Md.) 2013 Balwani M, Breen C, Enns GM, Deegan PB, Honzík T, Jones S, Kane JP, Malinova V, Sharma R, Stock EO, Valayannopoulos V, Wraith JE, Burg J, Eckert S, Schneider E, Quinn AG
• Cardiovascular disease in women.
  Current problems in cardiology 2012 Stock EO, Redberg R
• Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats.
  The Journal of endocrinology 2008 Ricchiuti V, Lian CG, Oestreicher EM, Tran L, Stone JR, Yao T, Seely EW, Williams GH, Adler GK
• Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).
  The American journal of cardiology 2007 O'Donoghue M, Kenney P, Oestreicher E, Anwaruddin S, Baggish AL, Krauser DG, Chen A, Tung R, Cameron R, Januzzi JL
• Amino-terminal pro-brain natriuretic peptide, brain natriuretic peptide, and troponin T for prediction of mortality in acute heart failure.
  Clinical chemistry 2007 Sakhuja R, Green S, Oestreicher EM, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB, Januzzi JL
• Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
  Endocrinology 2006 Guo C, Martinez-Vasquez D, Mendez GP, Toniolo MF, Yao TM, Oestreicher EM, Kikuchi T, Lapointe N, Pojoga L, Williams GH, Ricchiuti V, Adler GK
• Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists.
  Fertility and sterility 2005 López JM, Oestreicher E
• Bilateral oophorectomy in a pregnant woman: hormonal profile from late gestation to post-partum: case report.
  Human reproduction (Oxford, England) 2004 Villaseca P, Campino C, Oestreicher E, Mayerson D, Serón-Ferré M, Arteaga E
• Novel intronic mutation of MEN1 gene causing familial isolated primary hyperparathyroidism.
  The Journal of clinical endocrinology and metabolism 2004 Carrasco CA, González AA, Carvajal CA, Campusano C, Oestreicher E, Arteaga E, Wohllk N, Fardella CE
• Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
  Circulation 2003 Oestreicher EM, Martinez-Vasquez D, Stone JR, Jonasson L, Roubsanthisuk W, Mukasa K, Adler GK
• Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.
  Hypertension (Dallas, Tex. : 1979) 2002 Martinez DV, Rocha R, Matsumura M, Oestreicher E, Ochoa-Maya M, Roubsanthisuk W, Williams GH, Adler GK